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Background: Malaria cases attributed to Plasmodium falciparum account for approximately 600,000 deaths yearly,
mainly in African children. The gold standard method to diagnose malaria requires the visualization of the parasite
in blood. The role of non-invasive diagnostic methods to diagnose malaria remains unclear.
Methods: A protocol was optimized to deplete highly abundant proteins from saliva to improve the dynamic
range of the proteins identified and assess their suitability as candidate biomarkers of malaria infection. A starch-
based amylase depletion strategy was used in combination with four different lectins to deplete glycoproteins
(Concanavalin A and Aleuria aurantia for N-linked glycoproteins; jacalin and peanut agglutinin for O-linked
glycoproteins). A proteomic analysis of depleted saliva samples was performed in 17 children with fever and a
positive–malaria slide and compared with that of 17 malaria-negative children with fever.
Results: The proteomic signature of malaria-positive patients revealed a strong up-regulation of erythrocyte-
derived and inflammatory proteins. Three P. falciparum proteins, PFL0480w, PF08_0054 and PFI0875w, were
identified in malaria patients and not in controls. Aleuria aurantia and jacalin showed the best results for
parasite protein identification.
Conclusions: This study shows that saliva is a suitable clinical specimen for biomarker discovery. Parasite
proteins and several potential biomarkers were identified in patients with malaria but not in patients with other
causes of fever. The diagnostic performance of these markers should be addressed prospectively.Background
Malaria is an important public health problem causing
an estimated 216 million cases worldwide and approxi-
mately 655,000 deaths yearly. Most of these deaths occur
in sub-Saharan Africa and in children under five years of
age [1]. The current standard method to diagnose mal-
aria infection requires the visualization of the parasite in
blood using light microscopy. In addition to the discom-
fort caused by blood sampling, the use of invasive meth-
ods to diagnose malaria results in decreased study
completion rates in community studies when repeated
sampling is necessary. Saliva is a readily accessible, non-
invasive body fluid increasingly used as a diagnostic tool.* Correspondence: ccasals@well.ox.ac.uk
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reproduction in any medium, provided the orA previous study in Gambian children showing Plasmo-
dium falciparum DNA in saliva from malaria patients
underscores the suitability of this biofluid to diagnose
malaria. In this study, saliva could correctly identify up
to 82% of microscopy-positive samples [2].
The human saliva protein composition (proteome)
provides a suitable alternative to blood components for
biomarker discovery [3]. The salivary proteome has been
effectively used to identify markers of human disease
such as oral cancer and Sjögren’s syndrome [4,5].
Salivary secretions are a highly complex mixture of
proteins such as hormones and enzymes, lipids, carbohy-
drates and ions that contribute to the many roles and
functions of saliva. The composition of saliva results
from the contribution of the salivary glands, oral tissues
and oral micro-organisms [6]. The application of mass
spectrometry and biochemical techniques to salivaryLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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lysis of saliva [7]. To date, more than 1,400 proteins have
been identified in saliva. These salivary proteins have
been categorized into six structurally related groups: his-
tatins, proline-rich proteins (acidic, basic and glycosy-
lated), statherins and cystatins [8].
The complexity and the high dynamic range of salivary
proteins are the main obstacles to identifying potential
biomarkers in saliva using mass spectrometry as evi-
denced by highly-abundant proteins such as amylase,
which constitutes approximately 60% of the protein
composition of saliva [3,5,6]. Thus, the depletion of
highly abundant proteins prior to mass spectrometry
analysis is critical to maximize detection of less abun-
dant proteins that may be differentially expressed in
response to malaria infection.
Lectins are carbohydrate-binding proteins that revers-
ibly bind to specific mono- and oligosaccharides [9,10].
The reversibility of the lectin-sugar interactions makes
them appropriate for enrichment/depletion strategies.[9]
In this context, the differential binding affinities of lec-
tins makes them an effective tool for glycoproteomic re-
search. For example, concanavalin A (ConA) binds with
high mannose type N-glycans, whereas jacalin (Jac) se-
lectively binds immunoglobulins [11,12].
In this study, the potential of biochemical enrichment
methods of salivary proteins to identify potential biomar-
kers of malaria were optimized to enrich for Plasmodium
falciparum proteins.Methods
Study population
Matched samples of blood and saliva were collected
from children aged ≥10 years with suspected malaria in-
fection and referred for blood film microscopy at the
outpatient clinic facility of the Medical Research Council
in The Gambia. Patients were prospectively enrolled
before determination of malaria status. Saliva samples
(2 ml) were collected into separate aseptic Sterilin
bottles (Barloworld Scientific). All samples were kept at
4°C–8°C.
Saliva samples from 34 children with suspected mal-
aria were used for proteomic profiling studies. The sam-
ple workflow is outlined in Figure 1. Of these samples,
17 were confirmed as malaria positive and 17 as malaria
negative by light microscopy and by PCR as detailed
elsewhere [2]. All patients gave informed consent, and
parental or guardian consent was obtained for partici-
pants aged 18 years or younger. The study was jointly
reviewed and approved by the Gambian Government–
Medical Research Council Laboratories Ethics Commit-
tee and the Western Institutional Review Board and the
PATH Research Ethics Committee.Amylase depletion
Amylase depletion was carried out following the proto-
col reported by Deutsch et al. [3]. Briefly, pooled saliva
samples (N = 17) were centrifuged at 12,000 × g for
5 min at room temperature (RT) to remove insoluble
cell debris and food remnants. A 1 ml syringe (BD, REF
309002) with a 0.45 μm tip filter (Life Science, PN
K556T) was filled with 100 mg of potato starch (Sigma
S4251) per 100 μl saliva sample. The starch was moistur-
ized with 500 μl of distilled water by hand pressing
(20 s) through the device. Saliva samples were loaded in
a 1:1 ratio with starch and hand pressed in the filter for
120 s. The flow-through was collected and then the
starch was eluted in a column with 1X SDS-PAGE load-
ing buffer. Amylase depletion was confirmed by band
visualization in a silver-stained SDS protein gel
(Additional file 1). Initially, the ratio of saliva to starch
was optimized by testing the depletion of amylase at
various volumes of saliva sample. The starch was fixed
at 100 mg and used to deplete 50, 100, 200, 300, 400 μl
of saliva sample.
The volume of lectin beads was fixed at 50 μl and used
to deplete 50, 100, 200, 300, 400 μl of amylase-depleted
saliva samples. Each fraction, flow through (FT), wash
(W), elute (E) and SDS-elute (SDS) were collected and
analysed by SDS-PAGE.
Glycoprotein depletion using lectins
Glycoprotein enrichment/depletion was performed
according to the manufacturer’s instructions for all lec-
tins and additionally for ConA as described by Alonzi
et al. for ConA [13].
Concanavalin A (ConA) (Sigma Aldrich, Steinheim,
Germany) (100 μl): lectin beads were pre-equilibrated
with 2 × 1 ml H2O (Milli-Q) followed by 1 ml of 1 mM
MgCl2, 1 mM CaCl2 and 1 mM MnCl2 in water. The
beads were then washed with 2 × 1 ml 50 mM Tris/HCl
pH 7.2 prior to the addition of 100 μl of the starch-
depleted sample. The sample was incubated at 4°C for
1 h on a rotator. The supernatant was then collected by
centrifugation at 1,500 rpm. The pellet was washed with
1 ml 50 mM Tris/HCl buffer pH 7.2 and the supernatant
was collected. The pellet was washed again with 1 ml
water but the supernatant was not collected. 1 ml of hot
(70°C) 0.2 M α-methyl-mannoside was used to elute
bound glycoproteins and the supernatant was collected.
A second elute with 1 ml of hot (70°C) 0.2 M α- methyl-
glucoside was used and the supernatant was collected
before a final elution with 50 μl 2X SDS loading buffer.
Aleuria aurantia (AAL) (Vectors laboratories, Burlin-
game, CA, USA) (100 μl): The lectin beads were pre-
equilibrated with 2 × 1 ml 10 mM HEPES pH 7.5 fol-
lowed by 1 ml of 1 mM MgCl2, 1 mM CaCl2, and 1 mM
MnCl2. The 100 μl sample was added to the beads and
Figure 1 Study outline. OPD: outpatient department, ConA: Concanavalin A, Jac: Jacalin, PNA: peanut agglutinin, AAL: Aleuria aurantia, FT: flow-
through fraction, MS/MS: tandem-mass spectrometry.
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the supernatant. The pellet was then washed with
2 × 0.5 ml HEPES pH 7.5, centrifuged and the super-
natant was collected. Glycoproteins were eluted with
0.5 ml of 0.1 ML-fucose in PBS buffer, before a final elu-
tion with 50 μl 2X SDS loading buffer.
Jacalin (Jac) (Vectors Laboratories, Burlingame, CA,
USA) (100 μl): The lectin beads were pre-equilibrated
with 2 × 1 ml 175 mM Tris pH 7.5 before adding 100 μl
of sample and incubating at 4°C for 1 h on a rotator,
then collecting the supernatant by spinning down at
1,500 rpm. The pellet was washed with 2 × 1 ml 175 mM
Tris pH 7.5, centrifuged at 2,000 rpm for 30 s and the
wash buffer was collected. Glycoproteins were eluted
using 1 ml 0.8 M galactose in 175 mM Tris pH 7.5 be-
fore a further elution with 50 μl 2X SDS loading buffer.
Peanut agglutinin (PNA) (Vectors laboratories, Burlin-
game, CA, USA) (100 μl): The lectin beads were pre-
equilibrated with 2 × 1 ml 10 mM HEPES pH 7.5 and
activated with wash buffer of 0.1 mM CaCl2 and
0.01 mM MnCl2 in 10 mM HEPES pH 7.5. A 100 μl
sample was added to the beads and incubated at 4°C for
1 h on a rotator. The supernatant was then collected by
centrifugation at 1,500 rpm. Lectin beads were washed
with 1 × 1 ml 10 mM HEPES pH 7.5, centrifuged andthe supernatant was collected. Bound glycoproteins were
eluted with 1 ml 200 mM galactose in 10 mM HEPES
pH 3.0 before a further elution with 50 μl 2× SDS load-
ing buffer.
Protein precipitation (TCA/DOC procedure)
The amylase depleted/glycoprotein enriched sample
(1000 μl) was placed into a 1.5 ml centrifuge tube. Na-
deoxycholate (2% DOC) (125 μg/ml) was added (0.85 μl)
and vortexed at RT for 15 min. Then 33.3 μl 24%
trichloroacetic acid (TCA) was added and vortexed for
2 min before centrifuging at 12,000 rpm for 10 min at
4°C. The supernatant was aspirated carefully then washed
by centrifugation with 500 μl acetone (−20°C) to remove
excess TCA, then the supernatant was discarded and the
pellet resuspended in 50 μl 6 M urea, 50 mM Tris/HCl
loading buffer. Pierce BCA protein assay (Thermo Scien-
tific, Basingstoke, UK) was used for protein quantitation.
SDS PAGE electrophoresis
Equal amounts of proteins were separated onto a criter-
ion XT Bis-Tris gel 4–12% using XT MES running buf-
fer (Biorad, UK). Samples were loaded according to
protein quantitation and run at 25 mA/gel in 1× SDS
running buffer. After the separation of the proteins, the
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ston, UK) for 10 min and transferred in distilled water
for direct use or stored at 4°C overnight.
In-gel digestion protocol
Gel bands were cut using a sterile scalpel then further
cut into 1–2 mm3 gel pieces and transferred to a 1.5 ml
tube. The gel was covered in 200 μl of destaining solution
(50% methanol, 5% acetic acid in MilliQ-H2O) and
shaken at RT overnight. The destaining solution was
changed regularly until all the blue colour had been
removed. The gel pieces were dehydrated using 200 μl
acetonitrile for 5 min at RT and dried in a vacuum centri-
fuge for 2–3 min. Then 30 μl 10 mM dithiothreitol
(DTT) buffer was added to reduce for 30 min at RT be-
fore adding 30 μl 50 mM iodoacetamide buffer to alkylate
at RT for 30 min. Excess solution was removed before
adding 200 μl acetonitrile to dehydrate the gel pieces for
5 min at RT until white coloration appeared. The excess
acetonitrile was removed and the gel dried, then further
dried in a vacuum centrifuge for 2–3 min (or until com-
pletely dry). The trypsin reagent was prepared by adding
1 ml of ice-cold 50 mM ammonium bicarbonate to 20 μg
of trypsin (final concentration 20 ng/μl) and keeping the
solution on ice. Then a 30 μl trypsin solution was added
to the sample to rehydrate the gel pieces on ice for
10 min with gentle mixing. Gel pieces were spun down
for 30 s and the excess trypsin solution was removed.
Five μl 50 mM ammonium bicarbonate was added to the
gel pieces and the digestion was carried out overnight at
37°C with gentle mixing. Fifty mM ammonium bicarbon-
ate, 450 μl of extraction buffer 1 (50% acetonitrile, 5%
formic acid in MilliQ-H2O) and 50 μl of extraction buffer
2 (85% acetonitrile, 5% formic acid in MilliQ-H2O) were
successively added to the gel pieces for 10 min incuba-
tion and transferred into the same 1.5 ml tube. After the
last incubation in extraction buffer 2, the sample was
completely dried in a vacuum centrifuge, then resus-
pended in 20–40 μl of buffer A (98% MilliQ-H2O, 2%
acetonitrile, 0.1% formic acid).
Mass spectrometry
LC-MS/MS of peptides was performed using a Q-TOF
6520 (Agilent Technologies) equipped with a nanoLC-
chip cube. The HPLC consisted of a nanoflow analytical
and a capillary loading pump (Agilent 1200 series). Pep-
tides were enriched and separated via nano-LC
(0.075 × 150 mm, packed with Zorbax 300SB-C18, 5 μm
material, 300 Å pore size) integrated in the HPLC Chip
(G4240-62001). For each mass spectrometry experiment,
peptides were loaded onto the enrichment column with
100% solvent A (2% acetonitrile with 0.1% formic acid).
A two-step gradient generated at a flow rate 0.6 μl/min
was used for peptide elution. This included a lineargradient from 5% to 40% buffer B (95% acetonitrile with
0.1% formic acid) over 45 min followed by a sharp in-
crease to 100% B within 10 min. The total run time, in-
cluding column reconditioning, was 60 min. Lockmass
correction was performed using the poly (dimethylsilox-
ane ion ([M+H]1+ 445.1204 Da). Full scan was acquired
over a range of m/z 400–1700 at 5 spectra per sec, and
MS/MS over m/z 50–1700 at 2 spectra per sec selecting
the 6 most abundant doubly or triply charged precursors
per cycle. Spectra were deconvoluted and analysed using
Spectrum Mill (Agilent). Auto-MS/MS was performed
with a total cycle time of 3.3 s. Selected precursor
masses were ignored for 0.9 min.
MS/MS spectra generated above were extracted from
the raw data in mzXML file format using a converter
from the Agilent trapper. The mzXML data were sub-
mitted to the in house version of the Trans-Proteomic
Pipeline (TPP) [14] search for protein identification.
Spectral Index Quantitation (SINQ) [15] was used for
protein quantitation.
Results
Optimization of depletion strategies
In order to increase the number of less abundant pro-
teins identified in saliva samples, a series of protocols to
deplete highly abundant proteins from saliva were
optimized.
Amylase depletion
A starch-based depletion protocol was optimized and
used to remove amylase from saliva. The resulting flow
through fractions were then analysed by SDS-PAGE
(Figure 2). A 1:1 (μl of saliva: mg of starch) was suffi-
cient to significantly reduce the concentration of amyl-
ase. The efficiency of amylase depletion increased with
higher saliva to starch ratios.
Lectin depletion
Different lectins, Concanavalin A (ConA), Aleuria aur-
antia (AAL) Jacalin (Jac), and Peanut Agglutinin (PNA)
with various affinities for diverse sugar moieties were
used to deplete abundant N-linked (ConA, AAL) and O-
linked (Jac, PNA) glycoproteins from saliva. The previ-
ously mentioned lectins were used for depletion strat-
egy optimization. The ratio of lectin (volume of lectin-
conjugated beads) to the volume of amylase-depleted
sample was optimized. The results are shown in Additional
files 1, 2, 3 and 4). An optimal ratio of 1:2 (lectin to saliva,
v: v) was found to efficiently enrich certain glycoproteins
contained in saliva samples with minimal sample loss.
Lectin efficiency
The efficiency of the lectin depletion based on abun-
dance was analysed by assessing the sample loss in the
Figure 2 Protein separation of saliva samples from a healthy control depleted of amylase using potato starch with different saliva (μL
of saliva) to starch (μg of starch) ratios from 0.5:1 to 4:1. The figure shows the flow through fractions and the eluted fractions using 2 × SDS
loading buffer. Arrowhead denotes amylase band. Control denotes undepleted saliva sample from a healthy control. L = Ladder, E = Eluate,
Ctrl = Control.
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tion of each fraction for the four lectins was measured
using BCA assay protein quantitation. The ratio of total
concentration of protein obtained in the eluted fraction
to the total concentration of protein in the flow-through
fraction was used to compare the lectin-binding effi-
ciency. ConA and Jac showed the highest efficiency for
overall glycoprotein enrichment, and N- and O-linked
glycoproteins, respectively, as shown by the high con-
centration of protein recovered from the eluted fraction
(Figure 3). AAL and PNA did not appear to be as effect-
ive at glycoprotein enrichment, which could indicate
very tight binding requiring alternative elution condi-
tions. An apparent optimal protocol, from an efficiency
point of view, would combine the use of ConA and Jac.
However, glycoprotein efficiency here is a measure of
abundance and not the number of identifications dis-
played in Table 1 which suggests that AAL and not
ConA is the better choice of lectin for N-linked glyco-
protein depletion.
Mass Spectrometry analysis of depleted saliva samples
MS data was searched against a concatenated dataset of
Homo sapiens and the 3D7 P. falciparum isolate proteinsequences. A total of 1,955 peptides that corresponded to
192 proteins were identified at 1% false-discovery rate using
a target-decoy strategy. Protein identifications of patients
and control were compared using label-free methods.
Due to the low level of glycosylation of P. falcip-
arum proteins, [16] the lectin flow-through fraction
was expected to contain a higher number of parasite
protein identifications. Eleven peptides that corre-
sponded to four proteins assigned to P. falciparum
were identified in the flow-through fraction of all lec-
tins, namely PFL0480w, PF08_0054, PFI0875w and
PF13_0119. However, due to sequence homology of
these proteins with host proteins, only one parasite
protein (PFL0480w) was identified in the saliva flow-
through fraction with two or more peptides, and two
parasite proteins (PF08_0054 and PFI0875w) were
identified with one unique peptide, all of which could
be unequivocally assigned to P. falciparum (not shared
with host proteins).
The flow-through and eluted fractions were compared
using four different lectins in patients and controls in
order to identify candidate biomarkers found in the host
proteome. Most proteins uniquely identified by LC-MS/
MS in the saliva of malaria patients were plasma proteins.
Figure 3 Protein concentration obtained in each fraction of the Lectin depletion protocol in saliva samples. The graph shows the total
protein concentration (μg/μl) isolated in the flow-through fraction, wash and eluted fractions of lectin depletion protocols using ConA, AAL, PNA
and Jacalin. Error bars indicate standard error of the mean. ft = Flow through, w=wash, e1 = First eluted fraction, e2 = Second eluted fraction
(methyl α-glucoside).
Table 1 Unique proteins identified in the flow through





Concanavalin A Control 74 25
Patient 123 30
Jacalin Control 82 22
Patient 219 16
PNA Control 71 13
Patient 85 18
AAL Control 108 18
Patient 171 25
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Superoxide dismutase 2, mitochondrial
Heat shock 27kda protein 1
Peroxiredoxin 2

















Immunoglobulin heavy constant alpha 1
WD repeat domain 1
Lactotransferrin
Malate dehydrogenase 1, NAD (soluble)
Immunoglobulin heavy constant gamma 3 (G3m
marker)Comparison between malaria and non-malaria cases
also identified a number of differentially regulated
proteins (Tables 2 and 3). To minimize the false-dis-
covery rate for proteins differentially regulated in sal-
iva from malaria cases compared with non-malaria
cases, data were compiled from each of the lectins
and values were included only if proteins were up or
down regulated for a particular protein with at least
two different lectins.
The analysis of the number and identity of the unique
proteins obtained in the flow-through and eluted frac-
tions were used to measure how effective and specific
lectin-depletion was for patient and control saliva sam-
ples. The number of unique proteins identified in the
flow-through and eluted fractions per lectin depletion
strategy are shown in Table 1. AAL and Jac showed the
most number of identifications in the flow-through frac-
tions for N- and O-linked glycoproteins, respectively.
Table 2 List of proteins identified both in malaria cases
and in controls but increased in malaria patients
Proteins increased in malaria patients fold increase
Peptidylprolyl isomerase A (cyclophilin A) 23.17





Lymphocyte cytosolic protein 1 (L-plastin) 21.11





Histone cluster 2, h2be 20.25
Vesicle amine transport protein
1 homolog (T. Californica)
17.69
Heat shock 70kda protein 8 16.31




clade B (ovalbumin), member 13
11.84
Ribosomal protein s27a 11.73
Actin, beta-like 2 11.58
Cystatin SN 11.36
S100 calcium binding protein A9 11.03
Capping protein (actin filament), gelsolin-like 8.87
Leucine-rich alpha-2-glycoprotein 1 8.82
Bactericidal/permeability-increasing protein-like 1 5.55




Rho GDP dissociation inhibitor (GDI) beta 3.07
Table 3 List of proteins identified in saliva that are
decreased in malaria patients compared with non-malaria
febrile controls
Proteins decreased in malaria patients fold-decrease
Lipocalin 1 (tear prealbumin) 1.68
Thioredoxin 2.13
Single-chain Fv fragment 2.20
Dermcidin 3.03
Serpin peptidase inhibitor, clade B (ovalbumin), 3.22
Immunoglobulin heavy constant gamma 2
(G2m marker)
3.28
Immunoglobulin heavy constant mu 3.72
Immunoglobulin heavy constant alpha 1 4.65
Histone cluster 1, h1d unique in
controls
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Lectin-depletion strategies in combination with amylase
depletion are a simple and effective method to increase
the number of proteins identified in saliva at low con-
centrations, and thus potentially useful for biomarker
discovery studies in saliva. Although only two P. falcip-
arum proteins were identified in this study, the prote-
omic signature of saliva from malaria positive cases
revealed the up-regulation of a number of proteins asso-
ciated with haemolysis and inflammation compared with
febrile malaria-negative children.This study provides further evidence that saliva is a
non-invasive biological fluid suitable for the discovery of
biomarkers of disease. The presence of highly abundant
proteins in saliva, alpha-amylase in particular, is a clear
obstacle to identify potential protein biomarkers that
may be less abundant [3,17]. Thus, the optimization of
depletion strategies to identify less abundant proteins is
of paramount importance. Amylase-depletion was a
quick and highly effective method to increase the num-
ber of proteins identified in saliva. The proteomic ana-
lyses of starch-depleted samples indicated the absence of
amylase in the eluted and the flow-through fractions.
Due to the dynamic range of salivary proteins, add-
itional strategies to enrich for less abundant proteins are
essential. To accomplish this, the use of lectin-depletion
methods was explored. The rational for the inclusion of
a lectin-depletion step was to reduce at least partially
the high proportion of glycoproteins found in saliva and
to enrich for P. falciparum proteins. Although the extent
of glycosylation of Plasmodium spp proteins is largely
unresolved [16,18,19], there is evidence suggesting the
absence of glycosylation (N- and O- linked) in P. falcip-
arum. Indeed, the analysis of the Plasmodium genome
demonstrates a lack of the necessary glycosyl trans-
ferases required to catalyse this reaction [16]. Removal
of glycoprotein constituents of saliva using lectins was
therefore included in the sample processing workflow to
isolate potential, low abundant, non-glycosylated para-
site proteins. We therefore expected non-glycosylated
parasite proteins to be captured in the flow-through
fraction of all four lectins using N- (ConA, AAL) and O-
linked (Jac, PNA) specific lectins [11]. A number of pep-
tides associated with malaria samples were shared by the
host proteome and the protein sequences derived from
the P. falciparum 3D7 isolate. However, only three pro-
teins (PFL0480w, PF08_0054 and PFI0875w) could be
unequivocally assigned to 3D7 proteins. Other peptide
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P. falciparum 3D7 isolate and Homo sapiens.
These results support the idea that lectin depletion is
a useful method to increase dynamic range of protein
identifications from saliva samples. Due to the apparent
redundancy of the lectin-binding affinities, an optimal
protocol may not necessarily include all four lectins. In-
deed, Jac and ConA had the highest binding efficiency
whereas PNA and AAL proved to be less efficient deple-
tion strategies, suggesting that either the two lectins do
not bind strongly or specifically to glycoproteins present
in saliva. However, for this to be the case we would ex-
pect a larger concentration of protein to be captured in
the flow-through fraction unbound which was not
observed. Alternatively, it appears that non-specific or
very strong binding may have occurred preventing the
bound glycoproteins from subsequently being eluted by
the competitive inhibitors. This is demonstrated in the
second elution step in ConA which showed much higher
protein concentrations using methyl α-glucoside after
the first elution with methyl α-mannoside.
Identification of the proteins in the flow-through and
eluted fractions of each lectin depletion protocol pro-
vided further evidence on the effectiveness of each
strategy. Analysis of the number of unique proteins
identified by each lectin showed that Jac and AAL
identified the most number of unique proteins in the
flow-through fractions of malaria patients for O- and
N-linked glycoprotein depletion, respectively. For the
latter, the majority of the reported N-glycans in saliva
have been reported to be fucosylated on the core chito-
biose structure contributing to the higher number of
protein identifications in the flow-through of AAL than
ConA [20]. Jac binds to T-antigen glycans (Galβ3Gal-
NAc) with and without sialic acid residues whereas
PNA is more selective towards non-sialylated structures
[20]. The higher number of protein identifications in
the flow-through fractions of Jac suggests a higher
abundance of sialylated T-antigen glycans. Moreover,
analysis of the protein identification of each lectin pro-
vided valuable guidance to optimize the depletion
protocol. In addition to high abundance of α-amylase,
Krief et al. [17] showed that other abundant proteins
such as albumin and immunoglobulin may have similar
“masking effects” on the identification of less abundant
proteins. Immunoglobulin molecules are highly glycosy-
lated and were effectively removed by lectins. However,
90% of albumin is not glycosylated [21], and mass
spectrometry data showed its concentration was high
in the flow-through of AAL, PNA, Con A and Jac, the
eluted fraction of Con A and Jac but was undetectable
in the eluted fractions of AAL and PNA. Adding a
prior step to deplete albumin from saliva by sodium
chloride/ethanol albumin depletion may prove a usefulstrategy to increase the identification of parasite pro-
teins [22].
Analysis of the flow through fractions of patients and
controls identified 31 proteins that were uniquely
observed in the malaria patients. In particular, many of
the host proteins identified are predominantly found in
erythrocytes and 4 of 31 of the uniquely identified pro-
teins were constituents of haemoglobin (haemoglobin
epsilon 1, zeta, gamma A and delta). Peroxiredoxin 2 is
the second most abundant erythrocyte protein after
haemoglobin [23]. Other proteins that were unique or
up-regulated in malaria cases like calmodulin, fibrinogen
gamma chain and haptoglobin are associated with in-
flammation, endothelial vascular damage and haemoly-
sis. Indeed, red-cell rupture and inflammatory response
to parasite capture well the basic pathophysiology of
malaria. However, we considered alternative explana-
tions for these associations.
Fever is a clinical feature commonly accompanied by in-
flammation (increase vascular flow) of gums that could ac-
count for the leakage of plasma proteins into saliva.
However, since saliva samples from non-malaria patients
were also obtained from children with fever, it is unlikely
that this mechanism accounts for the differences observed
between patients and controls. It remains unclear whether
plasma proteins found in saliva are a consequence of vas-
cular damage induced by malaria parasites. Although the
scope of this study was mainly to provide evidence to sup-
port the suitability of saliva to identify clinically useful bio-
markers, the conclusion we can derive from our results
are limited by a number of factors. Due to reduced sample
volume available for these studies, we could not measure
the absolute concentration of our candidate markers in in-
dividual samples or perform extensive fractionation for in-
depth proteome analysis. This is a limitation of the study
as the use of pooled samples does not exclude the influ-
ence of individual samples in the selection of candidate
biomarkers. This limitation will be addressed in prospect-
ive studies.
Discovering biomarkers in saliva with a good diagnos-
tic performance is clinically relevant. From an oper-
ational perspective, the rapid identification of malaria
patients using saliva samples would immediately im-
prove triaging practices in outpatient departments. Simi-
larly, from a patient perspective we would anticipate that
patient compliance would increase in clinical or surveil-
lance studies that require frequent repeated sampling.Additional files
Additional file 1: Lectin depletion using Concanavalin A (ConA) and
optimization of starch depletion. The figure shows the optimization of
ConA depletion and starch depletion. (Key: L = Ladder, E = Elute, FT = Flow
Huang et al. Malaria Journal 2012, 11:178 Page 9 of 9
http://www.malariajournal.com/content/11/1/178Through, W1 =Wash 1, W2 =Wash 2, AR = Amylase-removed Control,
Ctrl = Control sample of saliva).
Additional file 2: Optimization of lectin depletion using AAL. The
figure shows the optimization of saliva sample volume, assessing the
effectiveness of 50 μg lectin depletion of 50, 100, 200 and 400 μl of
amylase removed saliva sample. The figure shows the differential band
patterns in the FT and E showing successful depletion strategies. (Key:
L = Ladder, E = Elute, FT = Flow Through, W=Wash, AR = Amylase
Removed Control, AR-E = Elute from the Starch used to remove amylase,
Ctrl = Control sample of saliva).
Additional file 3: Optimization of lectin depletion using jacalin. The
figure shows the optimization of saliva sample volume, assessing the
effectiveness of 50 μg lectin depletion of 50, 100, 200 and 400 μl of
amylase removed saliva sample. The figure shows the differential band
patterns in the FT and E showing successful depletion strategies. (Key:
L = Ladder, E = Elute, FT = Flow Through, W=Wash, SDS = Final Elute
using SDS loading buffer, AR = Amylase Removed Control, Ctrl = Control
sample of saliva).
Additional file 4: Optimization of lectin depletion using peanut
agglutinin (PNA). The figure shows the optimization of saliva sample
volume, assessing the effectiveness of 50 μg lectin depletion of 50, 100,
200 and 400 μl of amylase removed saliva sample. The figure shows the
differential band patterns in the FT and E showing successful depletion
strategies. (Key: L = Ladder, E = Elute, FT = Flow Through, W=Wash,
SDS = Final Elute using SDS loading buffer, AR = Amylase Removed
Control, Ctrl = Control sample of saliva).
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